Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Aytu Biopharma (AYTU) Current Taxes (2020)

Aytu Biopharma has reported Current Taxes over the past 1 years, most recently at $175000.0 for Q2 2020.

Quarterly Current Taxes changed N/A to $175000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $175000.0 through Jun 2020, changed N/A year-over-year, with the annual reading at $175000.0 for FY2020, N/A changed from the prior year.
Current Taxes was $175000.0 for Q2 2020 at Aytu Biopharma.
Over five years, Current Taxes peaked at $175000.0 in Q2 2020 and troughed at $175000.0 in Q2 2020.